First Time Loading...

Beigene Ltd
HKEX:6160

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
HKEX:6160
Watchlist
Price: 97.75 HKD 0.36% Market Closed
Updated: May 5, 2024

Beigene Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beigene Ltd
Revenue Peer Comparison

Comparables:
1801
603392
S
002252
300122
300896

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Beigene Ltd
HKEX:6160
Revenue
¥9.6B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Revenue
¥6.2B
CAGR 3-Years
17%
CAGR 5-Years
266%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Revenue
¥5.5B
CAGR 3-Years
33%
CAGR 5-Years
41%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Revenue
¥7.6B
CAGR 3-Years
41%
CAGR 5-Years
32%
CAGR 10-Years
27%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Revenue
¥49.7B
CAGR 3-Years
53%
CAGR 5-Years
65%
CAGR 10-Years
50%
Imeik Technology Development Co Ltd
SZSE:300896
Revenue
¥1.9B
CAGR 3-Years
51%
CAGR 5-Years
54%
CAGR 10-Years
N/A

See Also

What is Beigene Ltd's Revenue?
Revenue
9.6B CNY

Based on the financial report for Dec 31, 2022, Beigene Ltd's Revenue amounts to 9.6B CNY.

What is Beigene Ltd's Revenue growth rate?
Revenue CAGR 3Y
48%

Over the last year, the Revenue growth was 26%. The average annual Revenue growth rates for Beigene Ltd have been 48% over the past three years .